Emerging role of innate immunity in organ transplantation. Part I: Evolution of innate immunity and oxidative allograft injury

Transplantation Reviews

Volumn 26, Issue 2, 2012, Pages 60-72

  Land, Walter G ^a  

^a German Academy for Transplantation Medicine   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN PROTEIN; PATTERN RECOGNITION RECEPTOR; REACTIVE OXYGEN METABOLITE; TOLL LIKE RECEPTOR;

ADAPTIVE IMMUNITY; ALLOGRAFT; ALLOGRAFT INJURY; ANTIGEN PRESENTING CELL; CELL MATURATION; DENDRITIC CELL; DONOR; HUMAN; HYPOXIA; INNATE IMMUNITY; METAMORPHOSIS; MOLECULAR EVOLUTION; MOLECULAR RECOGNITION; NEUTROPHIL; NONHUMAN; ORGAN TRANSPLANTATION; OXIDATIVE STRESS; REPERFUSION INJURY; REVIEW; TISSUE INJURY;

EID: 84859006571     PISSN: 0955470X     EISSN: 15579816     Source Type: Journal    
DOI: 10.1016/j.trre.2011.05.001     Document Type: Review

References (74)

1. Janeway C.A. Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harb Symp Quant Biol 1989, 54:1-13.
2. Janeway C.A. The immune system evolved to discriminate infectious nonself from noninfectious self. Immunol Today 1992, 13:11-16.
3. Lemaitre B., Nicolas E., Michaut L., Reichhart J.M., Hoffmann J.A. The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell 1996, 86:973-983.
4. Poltorak A., He X., Smirnova I., et al. Defective LPS signaling in C3H/ HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 1998, 282:2085-2088.
5. Takeda K., Kaisho T., Akira S. Toll-like receptors. Annu Rev Immunol 2003, 21:335-376.
6. Matzinger P. Tolerance, danger, and the extended family. Annu Rev Immunol 1994, 12:991-1045.
7. Land W., Schneeberger H., Schleibner S., et al. The beneficial effect of human recombinant superoxide dismutase on acute and chronic rejection events in recipients of cadaveric renal transplants. Transplantation 1994, 57:211-217.
8. Oppenheim J.J., Tewary P., de la Rosa G., Yang D. Alarmins initiate host defense. AdvExp Med Biol 2007, 601:185-194.
9. Bianchi M.E. DAMPs, PAMPs and alarmins: all we need to know about danger. J LeukocBiol 2007, 81:1-5.
10. Beutler B. Neo-ligands for innate immune receptors and the etiology of sterile inflammatory disease. Immunol Rev 2007, 220:113-128.
11. Lotze M.T., Zeh H.J., Rubartelli A., et al. The grateful dead: damage-associated molecular pattern molecules and reduction/oxidation regulate immunity. Immunol Rev 2007, 220:60-81.
12. Klune J.R., Dhupar R., Cardinal J., Billiar T.R., Tsung A. HMGB1: endogenous danger signaling. Mol Med 2008, 14:476-484.
13. Zhang X., Mosser D.M. Macrophage activation by endogenous danger signals. J Pathol 2008, 214:161-178.
14. Manfredi A.A., Capobianco A., Bianchi M.E., Rovere-Querini P. Regulation of dendritic- and T-cell fate by injury-associated endogenous signals. Crit Rev Immunol 2009, 29:69-86.
15. Martinon F., Mayor A., Tschopp J. The inflammasomes: guardians of the body. Annu Rev Immunol 2009, 27:229-265.
16. Rock K.L., Latz E., Ontiveros F., Kono H. The sterile inflammatory response. Annu Rev Immunol 2010, 28:321-342.
17. Latz E. The inflammasomes: mechanisms of activation and function. Curr Opin Immunol 2010, 22:28-33.
18. Kanellopoulos-Langevin C., Caucheteux S.M., Verbeke P., Ojcius D.M. Tolerance of the fetus by the maternal immune system: role of inflammatory mediators at the feto-maternal interface. Reprod Biol Endocrinol 2003, 1:121.
19. Goldstein D.R., Tesar B.M., Akira S., Lakkis F.G. Critical role of the Toll-like receptor signal adaptor protein MyD88 in acute allograft rejection. J Clin Invest 2003, 111:1571-1578.
20. McKay D., Shigeoka A., Rubinstein M., Surh C., Sprent J. Simultaneous deletion of MyD88 and Trif delays major histocompatibility and minor antigen mismatch allograft rejection. Eur J Immunol 2006, 36:1994-2002.
21. Land W. Allograft injury mediated by reactive oxygen species: from conserved proteins of Drosophila to acute and chronic rejection of human transplants. Part III: interaction of (oxidative) stress-induced heat shock proteins with Toll-like receptor-bearing cells of innate immunity and its consequences for the development of acute and chronic allograft rejection. Transplant Rev 2003, 17:67-86.
22. Seong S.Y., Matzinger P. Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses. Nat Rev Immunol 2004, 4:469-478.
23. Land W.G. Innate alloimmunity. Part 1. Innate immunity and host defense 2011, Başkent University - Pabst Science Publishers, Ankara, Turkey.
24. Takeuchi O., Akira S. Pattern recognition receptors and inflammation. Cell 2010, 140:805-820.
25. Lavelle E.C., Murphy C., O'Neill L.A., Creagh E.M. The role of TLRs, NLRs, and RLRs in mucosal innate immunity and homeostasis. Mucosal Immunol 2010, 3:17-28.
26. Schroder K., Tschopp J. The inflammasomes. Cell 2010, 140:821-832.
27. Hornung V., Ablasser A., Charrel-Dennis M., et al. AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC. Nature 2009, 458:514-518.
28. Champsaur M., Lanier L.L. Effect of NKG2D ligand expression on host immune responses. Immunol Rev 2010, 235:267-285.
29. Banchereau J., Steiman R.M. Dendritic cells and the control of immunity. Nature 1998, 392:245-252.
30. Solari M.G., Thomson A.W. Human dendritic cells and transplant outcome. Transplantation 2008, 85:1513-1522.
31. Trombetta E.S., Mellman I. Cell biology of antigen processing in vitro and in vivo. Annu Rev Immunol 2005, 23:975-1028.
32. Morelli A.E., Thomson A.W. Tolerogenic dendritic cells and the quest for transplant tolerance. Nat Rev Immunol 2007, 7:610-621.
33. Steinman R.M., Hemmi H. Dendritic cells: translating innate to adaptive immunity. Curr Top Microbiol Immunol 2006, 311:17-58.
34. Blanco P., Palucka A.K., Pascual V., Banchereau J. Dendritic cells and cytokines in human inflammatory and autoimmune diseases. Cytokine Growth Factor Rev 2008, 19:41-52.
35. Mahnke K., Johnson T.S., Ring S., Enk A.H. Tolerogenic dendritic cells and regulatory T cells: a two-way relationship. J Dermatol Sci 2007, 46:159-167.
36. Land W.G. Innate alloimmunity. Part 2. Innate immunity and allograft rejection 2011, Başkent University - Pabst Science Publishers, Ankara, Turkey.
37. Afzali B., Lombardi G., Lechler R.I. Pathways of major histocompatibility complex allorecognition. Curr Opin Organ Transplant 2008, 13:438-444.
38. Champsaur M., Beilke J.N., Ogasawara K., Koszinowski U.H., Jonjic S., Lanier L.L. Intact NKG2D-independent function of NK cells chronically stimulated with the NKG2D ligand Rae-1. J Immunol 2010, 185:157-165.
39. Lanier L.L. NK cell recognition. Annu Rev Immunol 2005, 23:225-274.
40. Bendelac A., Savage P.B., Teyton L. The biology of NKT cells. Annu Rev Immunol 2007, 25:297-336.
41. Nanno M., Shiohara T., Yamamoto H., Kawakami K., Ishikawa H. Gammadelta T cells: firefighters or fireboosters in the front lines of inflammatory responses. Immunol Rev 2007, 215:103-113.
42. Faveeuw C., Mallevaey T., Trottein F. Role of natural killer T lymphocytes during helminthic infection. Parasite 2008, 15:384-388.
43. Paust S., Senman B., von Andrian U.H. Adaptive immune responses mediated by natural killer cells. Immunol Rev 2010, 235:286-296.
44. Munz C.h., Steinman R.M., Fujii S.I. Dendritic cell maturation by innate lymphocytes: coordinated stimulation of innate and adaptive immunity. J Exp Med 2005, 202:203-207.
45. Zitvogel L., Terme M., Borg C., Trinchieri G. Dendritic cell-NK cell cross-talk: regulation and physiopathology. Curr Top MicrobiolImmunol 2006, 298:157-174.
46. Reschner A., Hubert P., Delvenne P., Boniver J., Jacobs N. Innate lymphocyte and dendritic cell cross talk: a key factor in the regulation of the immune response. Clin Exp Immunol 2008, 152:219-226.
47. Land W., Messmer K. The impact of ischemia/reperfusion injury on specific and non-specific, early and late chronic events after organ transplantation. Early events. Transplant Rev 1996, 10:108-127.
48. Land W., Messmer K. The impact of ischemia/reperfusion injury on specific and non-specific, early and late chronic events after organ transplantation. Late chronic events. Transplant Rev 1996, 10:236-253.
49. Land W. Allograft injury mediated by reactive oxygen species: from conserved proteins of Drosophila to acute and chronic rejection of human transplants. Part I: demonstration of reactive oxygen species in reperfused allografts and their role in the initiation of innate immunity. Transplant Rev 2002, 16:192-204.
50. Land W. Postischemic reperfusion injury to allografts-a case for innate immunity?. EurSurg Res 2002, 34:160-169.
51. Land W. Allograft injury mediated by reactive oxygen species: from conserved proteins of Drosophila to acute and chronic rejection of human transplants. Part II: role of reactive oxygen species in the induction of the heat shock response as a regulator of innate immunity. Transplantation Rev 2003, 17:31-44.
52. Land W.G. The role of postischemic reperfusion injury and other nonantigen-dependent inflammatory pathways in transplantation. Transplantation 2005, 79:505-514.
53. Turrens J.F. Mitochondrial formation of reactive oxygen species. J Physiol 2003, 552:335-344.
54. Dröse S., Brandt U. The mechanism of mitochondrial superoxide production by the cytochrome bc1 complex. J BiolChem 2008, 283:21649-21654.
55. Baudry N., Laemmel E., Vicaut E. In vivo reactive oxygen species production induced by ischemia in muscle arterioles of mice: involvement of xanthine oxidase and mitochondria. Am J Physiol Heart Circ Physiol 2008, 294:H821-H828.
56. Harrison R. Physiological roles of xanthine oxidoreductase. Drug Metab Rev 2004, 36:363-375.
57. Vorbach C., Harrison R., Capecchi M.R. Xanthine oxidoreductase is central to the evolution and function of the innate immune system. Trends Immunol 2003, 24:512-517.
58. Zweier J.L., Talukter M.A.H. The role of oxidants and free radicals in reperfusion injury. Cardiovasc Res 2006, 70:181-190.
59. Sasaki M., Joh T. Oxidative stress and ischemia-reperfusion injury in gastrointestinal tract and antioxidant, protective agents. J Clin Biochem Nutr 2007, 40:1-12.
60. Bedard K., Krause K.H. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev 2007, 87:245-313.
61. Lassegue B., Griendling K.K. NADPH oxidases: functions and pathologies in the vasculature. Arterioscler Thromb Vasc Biol 2010, 30:653-661.
62. Messmer K., Menger M.D., Land W. Microcirculation in organ transplantation. Progr Applied Microcirculation 1995, Vol. 21. Karger AG, Basel, Switzerland.
63. Montalvo-Jave E.E., Escalante-Tattersfield T., Ortega-Salgado J.A., Piña E., Geller D.A. Factors in the pathophysiology of the liver ischemia-reperfusion injury. J Surg Res 2008, 147:153-159.
64. Nauseff W.M. Assembly of the phagocyte NADPH oxidase. Histochem Cell Biol 2004, 122:277-291.
65. Jaeschke H. Mechanisms of liver injury. II. Mechanisms of neutrophil-induced liver cell injury during hepatic ischemia-reperfusion and other acute inflammatory conditions. Am J Physiol Gastrointest Liver Physiol 2006, 290:G1083-G1088.
66. Fay A.J., Qian X., Jan Y.N., Jan L.Y. SK channels mediate NADPH oxidase-independent reactive oxygen species production and apoptosis in granulocytes. ProcNatlAcadSci USA 2006, 103:17548-17553.
67. Zmijewski J.W., Lorne E., Banerjee S., Abraham E. Participation of mitochondrial respiratory complex III in neutrophil activation and lung injury. Am J Physiol Lung Cell Mol Physiol 2009, 296:L624-L634.
68. Semenza G.L. Hydroxylation of HIF-1: oxygen sensing at the molecular level. Physiology (Bethesda) 2004, 19:176-182.
69. Smith T.G., Robbins P.A., Ratcliffe P.J. The human side of hypoxia-inducible factor. Br J Haematol 2008, 141:325-334.
70. Chandel N.S. Mitochondrial regulation of oxygen sensing. Adv Exp Med Biol 2010, 661:339-354.
71. Rathore R., Zheng Y.M., Niu C.F., Liu Q.H., Korde A., Ho Y.S., Wang Y.X. Hypoxia activates NADPH oxidase to increase [ROS]i and [Ca2+]i through the mitochondrial ROS-PKC epsilon signaling axis in pulmonary artery smooth muscle cells. Free Radic Biol Med 2008, 45:1223-1231.
72. Griguer C.E., Oliva C.R., Kelley E.E., Giles G.I., Lancaster J.R., Gillespie G.Y. Xanthine oxidase-dependent regulation of hypoxia-inducible factor in cancer cells. Cancer Res 2006, 66:2257-2263.
73. Angelos M.G., Kutala V.K., Torres C.A., He G., Stoner J.D., Mohammad M., Kuppusamy P. Hypoxic reperfusion of the ischemic heart and oxygen radical generation. Am J Physiol Heart Circ Physiol 2006, 290:H341-H347.
74. Rada B., Leto T.L. Oxidative innate immune defenses by Nox/Duox family NADPH oxidases. Contrib Microbiol 2008, 15:164-187.